Consistent with this notion, previous studies have demonstrated that hepcidin expression is upregulated in several types of cancer, including breast cancer, renal cell carcinoma (RCC), pancreatic cancer, prostate cancer, and colorectal cancer (23). The gene discussed is HAMP; the disease is renal cell carcinoma.